{"id":942399,"date":"2026-03-05T16:04:14","date_gmt":"2026-03-05T21:04:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/"},"modified":"2026-03-05T16:04:14","modified_gmt":"2026-03-05T21:04:14","slug":"caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/","title":{"rendered":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets<\/b><\/p>\n<p><i>First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference<\/i><\/p>\n<p>BRISBANE, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCareDx, Inc. (Nasdaq: CDNA) \u2014 The Transplant Company\u2122, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high\u2011value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx\u2122, an AI\u2011powered, cloud\u2011native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real\u2011world evidence development.<\/p>\n<p>\nVANTx is designed for secure, scalable cohort analysis across longitudinal patient timelines that enables the evaluation of treatment trends, patient outcomes, and practice patterns. The platform is intended to support clinicians, transplant programs, and pharma partners in testing hypotheses to generate actionable findings for treatment protocol development, investigator-initiated studies, and clinical trial design.<\/p>\n<p>\nJing Huang, Chief Data and AI Officer of CareDx, will be introducing VANTx at the Precision Medicine World Conference (PMWC) in Silicon Valley, California, on March 5, 2026, during the session \u201cTransforming Transplant Care Through AI: From Predictive Insights to Precision Decisions.\u201d The presentation will take place as part of the \u201cAI in Clinical Decision Support\u201d track.<\/p>\n<p>\n\u201cAs the market leader in transplant precision diagnostics and patient care solutions, we can help our transplant center partners generate actionable insights using LLMs and other models.\u201d said Jing Huang, Chief Data and AI Officer at CareDx. \u201cI joined CareDx to lead the development of the VANTx platform and to help transplant teams and researchers make sense of complex, longitudinal data in a way that is intuitive, clinically meaningful, and actionable. I am thrilled to see this vision and the investment we have made over the past 24 months in AI architecture starting to become a reality in support of transplant care globally.\u201d<\/p>\n<p>\nVANTx operates on a live data pipeline of CareDx\u2019s continuously expanding, multidimensional data repository of de-identified molecular tests and clinical trial data, with the ability to incorporate additional data at the transplant center\u2019s request including EMR, care quality, and remote patient monitoring data. VANTx receives real\u2011time ingestion from laboratory and clinical data sources and is built on a Databricks environment that leverages the Llama 3 foundational model and other advanced machine-learning techniques optimized for structured clinical data. Additionally, VANTx will incorporate validated predictive and prognostic insights models from KOAR, SHORE, ALAMO, and MAPLE with the goal of supporting kidney, heart, lung, and liver transplant research, respectively. These models are intended to inform sub-analyses of predicted disease risk in areas of significant research interest to the clinical community such as delayed graft function, microvascular inflammation, antibody mediated rejection, cardiac allograft vasculopathy, and cancer risk.<\/p>\n<p>\nVANTx is available to transplant centers through consultation with CareDx\u2019s medical affairs team today, and the company intends to make it available through self-service permission-based access to clinicians later in 2026.<\/p>\n<p><b>About CareDx<\/b><\/p>\n<p>\nCareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company\u2019s integrated solutions include non\u2011invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics\u2011based information for transplant patients. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.caredx.com%2F&amp;esheet=54439475&amp;newsitemid=20260305457319&amp;lan=en-US&amp;anchor=www.caredx.com&amp;index=1&amp;md5=e3257d627b31b5b9e0abb017df856dbd\">www.caredx.com<\/a>.<\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p>\nThis press release includes forward-looking statements related to CareDx including statements regarding the potential benefits and results that may be achieved with VANTx, AlloSure, AlloMap, and HeartCare. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that CareDx does not realize the expected benefits of VANTx, AlloSure, AlloMap, and HeartCare, risks that the findings in the data may be inaccurate, general economic and market factors, and other risks discussed in CareDx\u2019s filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by CareDx with the SEC on February 25, 2026, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx\u2019s actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx\u2019s forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260305457319\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260305457319\/en\/<\/a><\/span><\/p>\n<p><b>CareDx, Inc.<br \/>\n<\/b><br \/>Media<br \/>\n<br \/>Natasha Moshirian Wagner<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:nwagner@CareDx.com\"><b>nwagner@CareDx.com<\/b><\/a><\/p>\n<p><b>I<\/b>nvestor Relations<br \/>\n<br \/>Caroline Corner<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investor@CareDx.com\"><b>investor@CareDx.com<\/b><\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Managed Care Software Other Health Professional Services Data Management Apps\/Applications Technology Artificial Intelligence Data Analytics Other Professional Services Practice Management Other Technology Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260305457319\/en\/2559419\/3\/CareDx_updated_logo_2025.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; CareDx, Inc. (Nasdaq: CDNA) \u2014 The Transplant Company\u2122, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high\u2011value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx\u2122, an AI\u2011powered, cloud\u2011native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real\u2011world evidence development. VANTx is designed for secure, scalable cohort analysis across longitudinal patient timelines that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942399","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; CareDx, Inc. (Nasdaq: CDNA) \u2014 The Transplant Company\u2122, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high\u2011value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx\u2122, an AI\u2011powered, cloud\u2011native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real\u2011world evidence development. VANTx is designed for secure, scalable cohort analysis across longitudinal patient timelines that &hellip; Continue reading &quot;CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-05T21:04:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets\",\"datePublished\":\"2026-03-05T21:04:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/\"},\"wordCount\":879,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/\",\"name\":\"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-03-05T21:04:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/","og_locale":"en_US","og_type":"article","og_title":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk","og_description":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; CareDx, Inc. (Nasdaq: CDNA) \u2014 The Transplant Company\u2122, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high\u2011value healthcare solutions for transplant patients and caregivers, today announced the launch of VANTx\u2122, an AI\u2011powered, cloud\u2011native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real\u2011world evidence development. VANTx is designed for secure, scalable cohort analysis across longitudinal patient timelines that &hellip; Continue reading \"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-05T21:04:14+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets","datePublished":"2026-03-05T21:04:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/"},"wordCount":879,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/","name":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-03-05T21:04:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260305457319r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-announces-vantx-an-ai-powered-clinical-data-analytics-platform-built-on-caredxs-proprietary-large-scale-longitudinal-solid-organ-transplant-datasets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CareDx Announces VANTx\u2122, an AI\u2011Powered Clinical Data &amp; Analytics Platform Built on CareDx\u2019s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942399"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942399\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}